Self-Assembled Colloidal Gel Using Cell Membrane-Coated Nanosponges as Building Blocks
Source abstract
Abstract
Colloidal gels consisting of oppositely charged nanoparticles are increasingly utilized for drug delivery and tissue engineering. Meanwhile, cell membrane-coated nanoparticles are becoming a compelling biomimetic system for innovative therapeutics. Here, we demonstrate the successful use of cell membrane-coated nanoparticles as building blocks to formulate a colloidal gel that gelates entirely based on material self-assembly without chemical cross-linking. Specifically, we prepare red blood cell membrane-coated nanosponges and mix them with an appropriate amount of cationic nanoparticles, resulting in a spontaneously formed gel-like complex. Rheological test shows that the nanosponge colloidal gel has pronounced shear-thinning property, which makes it an injectable formulation. The gel formulation not only preserves the nanosponges' toxin neutralization capability but also greatly prolongs their retention time after subcutaneous injection into mouse tissue. When tested in a mouse model of subcutaneous group A Streptococcus infection, the nanosponge colloidal gel shows significant antibacterial efficacy by markedly reducing skin lesion development. Overall, the nanosponge colloidal gel system is promising as an injectable formulation for therapeutic applications such as antivirulence treatment for local bacterial infections.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Polymer Surface Interaction Studies · Hydrogels: synthesis, properties, applications · Pickering emulsions and particle stabilization
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Nanoengineering, ‡Moores Cancer Center, §Department of Pediatrics, ∥Skaggs School of Pharmacy and Pharmaceutical Sciences, ⊥Department of Bioengineering, and #Sanford Consortium for Regenerative Medicine, University of California San Diego, La Jolla, California 92093, United States
Funding
National Institute of Allergy and Infectious Diseases · Defense Threat Reduction Agency
References (37)
Show source-provided references
1. 10.1088/0953-8984/19/32/32310110.1088/0953-8984/19/32/323101 ↗
2. 10.1146/annurev-chembioeng-060713-04023010.1146/annurev-chembioeng-060713-040230 ↗
3. 10.1146/annurev-conmatphys-030212-18421310.1146/annurev-conmatphys-030212-184213 ↗
4. 10.1002/adhm.20150007610.1002/adhm.201500076 ↗
5. 10.1007/s10439-016-1583-910.1007/s10439-016-1583-9 ↗
6. 10.1038/ncomms729510.1038/ncomms7295 ↗
7. 10.1002/adma.20160467210.1002/adma.201604672 ↗
8. 10.1016/j.biomaterials.2010.02.05210.1016/j.biomaterials.2010.02.052 ↗
9. 10.1021/nn400630x10.1021/nn400630x ↗
10. 10.1002/adma.20070209910.1002/adma.200702099 ↗
11. 10.1089/ten.tea.2013.007510.1089/ten.tea.2013.0075 ↗
12. 10.1056/NEJMra091227310.1056/NEJMra0912273 ↗
13. 10.1007/s11095-016-1958-510.1007/s11095-016-1958-5 ↗
14. 10.1073/pnas.110663410810.1073/pnas.1106634108 ↗
15. 10.1038/nnano.2013.5410.1038/nnano.2013.54 ↗
16. 10.1038/nature1537310.1038/nature15373 ↗
17. 10.1039/C3NR06371B10.1039/C3NR06371B ↗
18. 10.1021/nl500618u10.1021/nl500618u ↗
19. 10.1038/nnano.2012.21210.1038/nnano.2012.212 ↗
20. 10.1021/nl504798g10.1021/nl504798g ↗
21. 10.1002/aic.1473510.1002/aic.14735 ↗
22. 10.1038/nnano.2013.25410.1038/nnano.2013.254 ↗
23. 10.1002/adma.20170164410.1002/adma.201701644 ↗
24. 10.1039/C6NR00535G10.1039/C6NR00535G ↗
25. 10.1021/nn501040h10.1021/nn501040h ↗
26. 10.1002/adma.20150107110.1002/adma.201501071 ↗
27. 10.1073/pnas.141242011110.1073/pnas.1412420111 ↗
28. 10.1002/jbm.a.3300010.1002/jbm.a.33000 ↗
29. 10.1021/nn500110a10.1021/nn500110a ↗
30. 10.1038/nmicrobiol.2016.15510.1038/nmicrobiol.2016.155 ↗
31. 10.1073/pnas.160616011310.1073/pnas.1606160113 ↗
32. 10.1128/CMR.00101-1310.1128/CMR.00101-13 ↗
33. 10.1016/S0140-6736(02)07371-310.1016/S0140-6736(02)07371-3 ↗
34. 10.1128/IAI.00636-0910.1128/IAI.00636-09 ↗
35. 10.1016/j.jconrel.2017.01.01610.1016/j.jconrel.2017.01.016 ↗
36. 10.1039/c3nr03064d10.1039/c3nr03064d ↗
37. 10.1038/nbt.307110.1038/nbt.3071 ↗